Bryn Mawr Trust Advisors LLC Takes $1.76 Million Position in Waters Corporation $WAT

Bryn Mawr Trust Advisors LLC acquired a new position in shares of Waters Corporation (NYSE:WAT) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 5,914 shares of the medical instruments supplier’s stock, valued at approximately $1,761,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of WAT. SG Americas Securities LLC grew its holdings in shares of Waters by 543.8% during the fourth quarter. SG Americas Securities LLC now owns 37,244 shares of the medical instruments supplier’s stock worth $14,146,000 after buying an additional 31,459 shares in the last quarter. Banque Cantonale Vaudoise grew its stake in Waters by 329.0% in the 4th quarter. Banque Cantonale Vaudoise now owns 4,294 shares of the medical instruments supplier’s stock worth $1,631,000 after acquiring an additional 3,293 shares during the period. Nordea Investment Management AB grew its stake in Waters by 15.8% in the 4th quarter. Nordea Investment Management AB now owns 13,550 shares of the medical instruments supplier’s stock worth $5,177,000 after acquiring an additional 1,848 shares during the period. Graybill Wealth Management LTD. acquired a new position in Waters in the 3rd quarter valued at $2,591,000. Finally, Rockefeller Capital Management L.P. lifted its stake in shares of Waters by 106.7% during the 4th quarter. Rockefeller Capital Management L.P. now owns 2,751 shares of the medical instruments supplier’s stock worth $1,045,000 after purchasing an additional 1,420 shares during the period. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Waters Trading Up 1.0%

NYSE WAT opened at $376.81 on Wednesday. The company’s fifty day simple moving average is $360.75 and its 200-day simple moving average is $346.51. Waters Corporation has a 52 week low of $275.05 and a 52 week high of $414.15. The company has a current ratio of 1.79, a quick ratio of 1.13 and a debt-to-equity ratio of 0.32. The stock has a market cap of $37.00 billion, a P/E ratio of 47.88, a PEG ratio of 2.26 and a beta of 1.20.

Waters (NYSE:WAT) last announced its earnings results on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share for the quarter, beating the consensus estimate of $2.31 by $0.39. The business had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.20 billion. Waters had a net margin of 11.91% and a return on equity of 15.60%. The business’s quarterly revenue was up 91.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.25 earnings per share. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. Equities research analysts predict that Waters Corporation will post 14.51 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on WAT shares. Wall Street Zen raised Waters from a “hold” rating to a “buy” rating in a research report on Sunday. HSBC raised their price target on Waters from $415.00 to $435.00 and gave the stock a “buy” rating in a research note on Wednesday, June 3rd. Wells Fargo & Company upped their price objective on shares of Waters from $355.00 to $370.00 and gave the company an “equal weight” rating in a research note on Thursday, May 14th. UBS Group raised their target price on shares of Waters from $330.00 to $375.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Finally, Evercore reaffirmed an “outperform” rating and set a $410.00 price target on shares of Waters in a research report on Monday, July 6th. Three equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $401.60.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.